Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 7 studies | 17% ± 1% | |
endothelial cell | 6 studies | 21% ± 3% | |
classical monocyte | 4 studies | 23% ± 5% |
Insufficient scRNA-seq data for expression of MLKL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 962.86 | 359 / 359 | 100% | 14.68 | 285 / 286 |
intestine | 99% | 1320.45 | 961 / 966 | 100% | 15.94 | 527 / 527 |
esophagus | 99% | 1217.29 | 1437 / 1445 | 100% | 12.92 | 183 / 183 |
lung | 100% | 3415.62 | 578 / 578 | 99% | 10.75 | 1147 / 1155 |
bladder | 100% | 1195.52 | 21 / 21 | 98% | 11.06 | 495 / 504 |
breast | 100% | 1629.37 | 459 / 459 | 97% | 7.04 | 1085 / 1118 |
thymus | 100% | 1249.49 | 652 / 653 | 97% | 5.18 | 588 / 605 |
pancreas | 99% | 682.72 | 325 / 328 | 98% | 14.37 | 174 / 178 |
kidney | 100% | 1250.39 | 89 / 89 | 93% | 12.16 | 842 / 901 |
uterus | 100% | 1125.30 | 170 / 170 | 93% | 9.47 | 425 / 459 |
prostate | 100% | 1220.79 | 245 / 245 | 81% | 3.36 | 407 / 502 |
skin | 96% | 767.16 | 1734 / 1809 | 84% | 5.97 | 395 / 472 |
adrenal gland | 100% | 853.43 | 258 / 258 | 61% | 2.84 | 141 / 230 |
liver | 87% | 596.65 | 196 / 226 | 74% | 3.97 | 299 / 406 |
ovary | 59% | 313.68 | 107 / 180 | 68% | 2.87 | 293 / 430 |
adipose | 100% | 2128.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4879.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.61 | 1 / 1 |
peripheral blood | 100% | 3593.17 | 925 / 929 | 0% | 0 | 0 / 0 |
brain | 44% | 282.78 | 1163 / 2642 | 53% | 2.02 | 376 / 705 |
lymph node | 0% | 0 | 0 / 0 | 97% | 12.52 | 28 / 29 |
blood vessel | 94% | 975.18 | 1249 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 746.29 | 802 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 1.10 | 22 / 80 |
muscle | 25% | 99.02 | 198 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097527 | Biological process | necroptotic signaling pathway |
GO_0051607 | Biological process | defense response to virus |
GO_0070266 | Biological process | necroptotic process |
GO_0070207 | Biological process | protein homotrimerization |
GO_0097528 | Biological process | execution phase of necroptosis |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0030054 | Cellular component | cell junction |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | MLKL |
Protein name | Mixed lineage kinase domain-like protein (hMLKL) Mixed lineage kinase domain like pseudokinase |
Synonyms | |
Description | FUNCTION: Pseudokinase that plays a key role in TNF-induced necroptosis, a programmed cell death process . Does not have protein kinase activity . Activated following phosphorylation by RIPK3, leading to homotrimerization, localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage . In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following activation by ZBP1, MLKL is phosphorylated by RIPK3 in the nucleus, triggering disruption of the nuclear envelope and leakage of cellular DNA into the cytosol.following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Binds to highly phosphorylated inositol phosphates such as inositolhexakisphosphate (InsP6) which is essential for its necroptotic function . . |
Accessions | ENST00000571303.1 ENST00000573267.1 I3L2T9 Q8NB16 ENST00000308807.12 [Q8NB16-1] ENST00000576529.1 ENST00000306247.11 [Q8NB16-2] I3L4A6 I3L4Z5 I3L2U3 ENST00000575686.1 |